Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM

Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM - Nebido®)

Published:2008-10 Issue:4 Volume:69 Page:642-647
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Moisey Robert,Swinburne Julie,Orme Steve

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2008.03251.x/fullpdf

Reference29 articles.

1. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies;Behre;European Journal of Endocrinology,1999

2. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism;Schubert;Journal of Clinical Endocrinology and Metabolism,2004

3. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study;Von Eckardstein;Journal of Andrology,2002

4. 4Bayer Schering Pharma, Bayer plc. (2006) Bayer House, Strawberry Hill, Newbury. RG14 1JA. Nebido 1000mg/4ml, for injections. Summary of Product Characteristics, November 2006.

5. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children;Taieb;Clinical Chemistry,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term testosterone undecanoate treatment in the elderly testosterone deficient male: An observational cohort study;Andrology;2021-11-23

2. Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men;Endocrine Connections;2021-07-01

3. Long‐term testosterone undecanoate replacement therapy: Impact of ethnicity;Clinical Endocrinology;2020-01-29

4. Effectiveness and tolerability of parenteral testosterone undecanoate: a post-marketing surveillance study;The Aging Male;2017-08-16

5. The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD);The Aging Male;2016-10-18